Mylan Laboratories, Inc. (NASDAQ:MYL)
The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
chicagolovesmone
(< 20)
Submitted: 7/7/2007 11:52:15 AM :
Start Price:
$18.15
MYL Score:
+28.38
One of the best generic drug makers, will smoke next earning.
Price target$26.50
Recs
helen1934
(< 20)
Submitted: 6/20/2007 12:56:51 PM :
Start Price:
$18.78
MYL Score:
-24.21
will show better cash flow after recent merger
Recs
Recs
ysu95
(45.84)
Submitted: 6/8/2007 11:52:50 PM :
Start Price:
$18.74
MYL Score:
-22.90
CEO Coury will buy just to expand power. The failed King acquisition has been replaced by a little better, but way too big, undertaking (Merck KGaA generic arm). Too much leverage, too much dilution, too much risk.
Recs
mbc5589
(< 20)
Submitted: 6/1/2007 8:36:51 PM :
Start Price:
$19.61
MYL Score:
+19.36
generic pharmacueticals always land on their feet and ultimately do well when a new product comes off patent.
Recs
EXLTUSN
(24.86)
Submitted: 5/26/2007 1:49:18 PM :
Start Price:
$19.71
MYL Score:
-17.85
They're glory days seem to be over. Better competition.
Recs
haikuguy
(< 20)
Submitted: 5/26/2007 1:03:06 PM :
Start Price:
$19.71
MYL Score:
-17.85
Will take a long time to digest the hefty price paid for new buy out plus the negative attitude of the market toward the purchase.
Recs
cummingsr
(< 20)
Submitted: 5/14/2007 3:51:44 PM :
Start Price:
$19.69
MYL Score:
+17.04
Demographics
Recs
bebw
(< 20)
Submitted: 4/10/2007 2:49:40 PM :
Start Price:
$21.74
MYL Score:
+3.01
As patents on more drugs run out they will be produced as generic and so Mylan will broaden it's inventory. Also, the HMO's like generic brands better!!!
Recs
nubblyman
(41.51)
Submitted: 3/1/2007 3:16:37 PM :
Start Price:
$20.16
MYL Score:
+7.91
Financials appear sound. The company appears priced at a significant discount compared to other pharmaceutical company's, with a P/E of ~13. There are not a lot of new blockbuster drugs. The older ones are falling off patent, and Mylan is agressively waiting to catch some. Sooner or later they will, which will provide growth. Meanwhile they're expanding abroad. I don't recommend anything I don't buy, but today would have been better day to buy than yesterday, when I did.
Recs
CycleFreak7
(< 20)
Submitted: 2/25/2007 11:14:13 AM :
Start Price:
$21.78
MYL Score:
+3.18
Despite being up 9.3% YTD 2007, it has recently pulled back from the high hit on 2-Feb of $22.61 for a 3.5% drop to $21.82.
Generics are the pharma of the future. Democrats want health care spending brought under control and will mandate more usage of generics.
Recs
boiler1111
(97.56)
Submitted: 2/22/2007 9:40:19 AM :
Start Price:
$20.14
MYL Score:
+8.08
Generics will continue to grow share of overall drug market. Not just growth, though, HUGE growth. In fact, by 2010, generics will have 80% share as opposed to <50% just recently. This whole sector will outperform, but I pick MYL as the one with the greatest margin of safety due to: attractive P/E and PEG, solid mgmt, and a divendend. (Yes a div on a generic). Be confident in this sector (generics) and in MYL particularly.
Recs
Recs
Recs
rcbeltz
(< 20)
Submitted: 2/6/2007 6:42:05 PM :
Start Price:
$22.32
MYL Score:
+0.28
Drugs are Good!
Recs
ferdie47
(< 20)
Submitted: 2/5/2007 4:03:13 PM :
Start Price:
$22.26
MYL Score:
+0.44
bunch of products in the pipeline
Recs
faythfullone
(< 20)
Submitted: 2/4/2007 8:07:21 PM :
Start Price:
$22.39
MYL Score:
-0.30
ithis stock has already had 3 FDA approvals in the past quarter and there are several more in their pipeline.
Recs
kellon100
(28.22)
Submitted: 1/31/2007 5:27:11 PM :
Start Price:
$22.47
MYL Score:
-1.02
Excellent management; superior generic products
Recs
mdinvestor
(< 20)
Submitted: 1/17/2007 3:50:46 PM :
Start Price:
$20.71
MYL Score:
+6.33
Generics, generics and more generics-their time has come
Recs
NetscribePhrmtcl
(92.11)
Submitted: 12/13/2006 8:09:13 AM :
Start Price:
$20.71
MYL Score:
+5.85
Mylan Labs knows that ‘you may not recognize its drugs but will appreciate the prices’. Mylan Labs is one of the largest manufacturers of prescription generic drugs in the US with its pharmaceutical cabinet full of 150 products, including anti-biotics, anti-depressants, anti-inflammatories, beta-blockers, and laxatives.
The recent approval by FDA to Mylan Lab’s generic version of the blockbuster drug Norvasc should augur well for the company when it is launched in September 2007 after the expiry of Pfizer’s Norvasc patent in March 2007. Norvasc used for the treatment of hypertension and blood pressure recorded sales of $4.7 billion in 2005. The potential for this market looks bright, as cardiovascular disease is the leading cause of death in the developed world. Nearly 2,500 Americans die of this disease each day.
Mylan Labs has announced the purchase of a financially sound Indian pharmaceutical company called Matrix Laboratories, which specializes in active pharmaceutical ingredient production (raw materials). The purpose of the acquisition is to go for backward integration and increase its presence not only in India but also in parts of Europe where Matrix operates through its Docpharma subsidiary. We expect to see similar acquisitions by the company in future.
One concern for the company is that its generic drug counterpart for Duragesic, which contributes 20% of the revenues, will face competition in coming months when Lavipharm will launch a similar drug. However, we believe that launch of generic version of Norvasc and acquisition will hold the company in good stead in 2007. Furthermore, the fact that nearly $19 billion shall be off patent protection during 2006, and another $10 billion during 2007, there exists a tremendous opportunity for generic drug manufacturers like Mylan Lab in the coming year.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 81 - 100 of 102 : « Previous 1 2 3 4 5 6 Next »